Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial

OBJECTIVES: To assess long-term efficacy of tocilizumab in treatment-naive patients with Takayasu arteritis (TAK). METHODS: Prospective open-labeled trial in naïve patients with TAK who received steroids at the dose of 0.7 mg/kg/day and 7 infusions of 8 mg/kg/month of tocilizumab. The primary endpoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mekinian, Arsene, Saadoun, David, Vicaut, Eric, Thietart, Sara, Lioger, Bertrand, Jego, Patrick, Bleibtreu, Alexandre, Limal, Nicolas, Connault, Jerome, Gottenberg, Jacques-Eric, Lhorte, Pauline, Bertola, Jean Pierre, Delforge, Juliette, Ferreira-Maldent, Nicole, Perlat, Antoinette, Talib, Zohra, Vautier, Matthieu, Savey, Léa, Quiere, Isabelle, Cacoub, Patrice, Fain, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500024/
https://www.ncbi.nlm.nih.gov/pubmed/32943098
http://dx.doi.org/10.1186/s13075-020-02311-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500024/
https://www.ncbi.nlm.nih.gov/pubmed/32943098
http://dx.doi.org/10.1186/s13075-020-02311-y

Ejemplares similares